FINWIRES · TerminalLIVE
FINWIRES

Leerink Partners Upgrades Edwards Lifesciences to Outperform From Market Perform, Adjusts PT to $101 From $87

By

Edwards Lifesciences (EW) has an average rating of overweight and mean price target of $100.98, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles

Research

Wells Fargo Downgrades Albertsons to Equal Weight From Overweight, $11 Price Target

Wells Fargo Downgrades Albertsons to Equal Weight From Overweight, $11 Price Target

$ACI
Research

Maxim Group Initiates Coverage on Cyabra With Buy Rating, $1 Price Target

Maxim Group Initiates Coverage on Cyabra With Buy Rating, $1 Price Target

$CYAB
Research

Capital One Downgrades Caesars Entertainment Inc to Equalweight From Overweight, Adjusts Price Target to $31 From $41

Caesars Entertainment Inc (CZR) has an average rating of hold and mean price target of $31.27, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $29.85, Change: $-0.10, Percent Change: -0.32%

$CZR